About the Authors
- Jian feng Zhu
-
Contributed equally to this work with: Jian feng Zhu, Zi jian Li
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Zi jian Li
-
Contributed equally to this work with: Jian feng Zhu, Zi jian Li
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Guang sen Zhang
-
* E-mail: zgsllzy@163.com (GsZ); kunm88@yahoo.com (KM)
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Kun Meng
-
* E-mail: zgsllzy@163.com (GsZ); kunm88@yahoo.com (KM)
Affiliation Shenogen Biomedical Co, Ltd, Beijing, Haidian, Beijing, People's Republic of China
- Wen yong Kuang
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Jin Li
-
Affiliation Shenogen Biomedical Co, Ltd, Beijing, Haidian, Beijing, People's Republic of China
- Xin fu Zhou
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Rui juan Li
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Hong ling Peng
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Chong wen Dai
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Jian Kai Shen
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Fan jie Gong
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Yun xiao Xu
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
- Su fang Liu
-
Affiliation Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, People's Republic of China
Competing Interests
Kun Meng and Jin Li are employees of Shenogen Biomedical Co, Ltd. The drug Icaritin was provided by Shenogen Biomedical Co, Ltd., who have the patent for the drug Icaritin (patent number 200710179673.8, date: 2007.12.17). There are no other products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: GsZ. Performed the experiments: JfZ ZjL WyK XfZ RjL HlP FjG SfL. Analyzed the data: JfZ GsZ ZjL KM. Contributed reagents/materials/analysis tools: KM JL CwD JKS YxX. Wrote the paper: GsZ.